Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: A physiologically based pharmacokinetic model

被引:42
作者
Yokogawa, K
Ishizaki, J
Ohkuma, S
Miyamoto, K
机构
[1] Kanazawa Univ, Sch Med, Dept Hosp Pharm, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Fac Pharmaceut Sci, Dept Mol & Cellular Biol, Kanazawa, Ishikawa 9208641, Japan
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2002年 / 24卷 / 02期
关键词
basic drug; disposition kinetics; distribution; lipophilicity; lysosome;
D O I
10.1358/mf.2002.24.2.677131
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper examines the role of lipophilicity in the tissue distribution kinetics of basic drugs. Basic drugs have a large distribution volume and are distributed widely in various tissues in the following order: lung, fat, heart, kidney, brain, gut, muscle and bone. The fat volume in the whole body influences the disposition kinetics. There is a good correlation in various tissues between the tissue-plasma concentration ratio and the octanol-water partition coefficient among various drugs. We constructed a physiologically-based pharmacokinetic model on the basis of drug lipophilicity and found that drug distribution decreased when NH4Cl was administered concomitantly. In regards to subcellular distribution, the relative specific contents of chlorpromazine, imipramine and biperiden with respect to the protein in lysosomes were 7.3, 9.6 and 4.2, respectively, while those in other subcellular organella, including mitochondria, were only 0.4-1.7, indicating preferential accumulation of these drugs in lysosomes. The uptake of basic drugs into lysosomes depended on both intralysosomal pH and drug lipophilicity. As the lipophilicity of the basic drugs increased, they accumulated more than would have been predicted from the pH-partition theory and raised the intralysosomal pH more potently, probably owing to their binding with lysosomal membranes, with or without intralysosomal aggregation. We conclude that the distribution kinetics of basic drugs is driven by drug lipophilicity and uptake into lysosomes, and these phenomena provide a possible basis for drug interaction in clinical treatments. (C) 2002 Prous Science. All rights reserved.
引用
收藏
页码:81 / 93
页数:13
相关论文
共 41 条
[1]   PHARMACOKINETICS OF HALOPERIDOL IN PSYCHOTIC-PATIENTS [J].
CHENG, YF ;
PAALZOW, LK ;
BONDESSON, U ;
EKBLOM, B ;
ERIKSSON, K ;
ERIKSSON, SO ;
LINDBERG, A ;
LINDSTROM, L .
PSYCHOPHARMACOLOGY, 1987, 91 (04) :410-414
[2]   LYSOSOMOTROPIC AGENTS [J].
DEDUVE, C ;
DEBARSY, T ;
POOLE, B ;
TROUET, A ;
TULKENS, P ;
VANHOOF, F .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (18) :2495-+
[3]   THE BIOAVAILABILITY OF ORAL AND PARENTERAL CHLORIMIPRAMINE (ANAFRANIL) [J].
EVANS, LEJ ;
BETT, JHN ;
COX, JR ;
DUBOIS, JP ;
VANHEES, T .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (03) :293-302
[4]   EXPRESSION CLONING OF A MAMMALIAN PROTON-COUPLED OLIGOPEPTIDE TRANSPORTER [J].
FEI, YJ ;
KANAI, Y ;
NUSSBERGER, S ;
GANAPATHY, V ;
LEIBACH, FH ;
ROMERO, MF ;
SINGH, SK ;
BORON, WF ;
HEDIGER, MA .
NATURE, 1994, 368 (6471) :563-566
[5]  
GREENBLATT DJ, 1989, J PHARMACOL EXP THER, V250, P134
[6]   INVITRO QUANTITATION OF BENZODIAZEPINE LIPOPHILICITY - RELATION TO INVIVO DISTRIBUTION [J].
GREENBLATT, DJ ;
ARENDT, RM ;
ABERNETHY, DR ;
GILES, HG ;
SELLERS, EM ;
SHADER, RI .
BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (10) :985-989
[7]   PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOLLOWING THE INTRAVENOUS AND ORAL-ADMINISTRATION OF THE ANTIPARKINSONIAN DRUG BIPERIDEN TO NORMAL SUBJECTS [J].
GRIMALDI, R ;
PERUCCA, E ;
RUBERTO, G ;
GELMI, C ;
TRIMARCHI, F ;
HOLLMANN, M ;
CREMA, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) :735-737
[8]   DRUG EXCRETION MEDIATED BY A NEW PROTOTYPE OF POLYSPECIFIC TRANSPORTER [J].
GRUNDEMANN, D ;
GORBOULEV, V ;
GAMBARYAN, S ;
VEYHL, M ;
KOEPSELL, H .
NATURE, 1994, 372 (6506) :549-552
[9]   CELLULAR ACCUMULATION OF AMIODARONE AND DESETHYLAMIODARONE IN CULTURED HUMAN-CELLS - CONSEQUENCES OF DRUG ACCUMULATION ON CELLULAR LIPID-METABOLISM AND PLASMA-MEMBRANE PROPERTIES OF CHRONICALLY EXPOSED CELLS [J].
HONEGGER, UE ;
ZUEHLKE, RD ;
SCUNTARO, I ;
SCHAEFER, MHA ;
TOPLAK, H ;
WIESMANN, UN .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) :349-356
[10]  
ICHIMURA F, 1984, INT J PHARM, V19, P75